icadmed.com

Skip to content Creating a world whereCancer Can’t Hide.Cancer wins when it hides. Remaining undetected, cancer poses one of the greatest threats to life. When cancer wins, we all lose. But what if cancer couldn’t hide? What if there was a way to expose where it may be hiding and when it’s going to make its move?Learn How iCAD finds cancer Previous Next 0  in 0women will get breast cancer in her lifetime. 0  – 0 %of cancers are missed in mammogram screenings. 0 secondsEvery 14 seconds, a woman is diagnosed with breast cancer world-wide. 0 %Assessing cancer risk with traditional models is only 63% accurate. 0 %33% of women miss their screening mammogram in a two-year span. 0 %Up to 50% of breast cancers are missed in women with dense breast tissue. 0 %89% of women diagnosed with breast cancer have no family history of the diseaseBreast cancer has finally met its match.Know where cancer may be hiding and when it might make its move. For PatientsWhen breast cancer is detected early, the 5-year relative survival rate is 99%.5 Find cancers at the earliest possible stage. Learn How For ProvidersFind more invasive cancers, and the interval cancers you fear the most, while cutting your reading time in half by adding ProFound to your workflow.4 Learn How Our PlatformProFound Breast Health SuiteBacked by science, clinical evidence, and proven patient outcomes; our suite of solutions – Detection, Density, and Risk* — shine a spotlight on cancer, exposing its hiding place.  These clinically proven AI-powered solutions provide certainty and peace of mind, improving patient outcomes and saving more lives.Schedule a Demo Detection Density Risk Detection CAncer DetectionA screening revolution has arrived. The difference is ProFound.Find cancers earlier, with greater accuracy and efficiency, with fewer recalls and improved workflows.4 Solutions available for 2D and 3D mammography, in both the US and globally in various countries.Learn How Density Density AssessmentObjective, reliable, consistent density scoring.Breast density can elevate breast cancer risk up to 4x,6 therefore, density scores impact and inform personalized treatment plans. Simplify and standardize assessments of breast density, with results clinicians rely on and patients understand.Learn How Risk Risk EvaluationKnow your risk. Protect your future.The world’s first image-based risk model is 2.4x more accurate than traditional models.1,2 Identify women at high risk of developing cancer before or at their next screening to help find interval cancers, earlier.ProFound AI Risk is CE Marked and Health Canada Licensed, is not FDA Cleared, and is only available in the US for investigational use.Learn HowWe work the way you want to work.Rapid implementation for a swift go-live.Flexible & secure deployment options for smooth IT adoption.Seamless integration within your workflow and systems you trust. About iCADRemaining unseen and insidious, hidden cancer poses one of the greatest threats to life. When cancer wins, we all lose. But what if cancer couldn’t hide? What if there was a way to expose where it may be hiding and when it’s going to make its move?Play VideoTHE PROOFPrecise, powerful, proven 0Years of Experience 0Available in 50 Countries 0Patents Granted 0Clinical Studies 0Clinical Sites sourcing Images for Algorithm Diversity 0  M+Million Images Trained Algorithm 0 thGeneration AI Algorithm 0FDA Cleared. CE Marked. Health Canada Licensed.*In the last five years alone, iCAD estimates reading more than 40 million mammograms worldwide, of which nearly 30% are tomosynthesis.learn more about icadExpert VoicesJoining forces against a common enemy.In the fight against cancer, we’re stronger together. Learn why our customers believe that our solutions are the secret weapon for cancer detection and treatment.View All Testimonials Previous Next As soon as we implemented ProFound AI, we started using it on all of our DBT breast cancer screenings. It greatly improved our workflow and enabled us to get back to rapid reads and offered the opportunity to provide results for patients in real-time. Lisa SheppardMD, PINK Breast Center After comparing all available options, we felt that iCAD’s technology was simply the best. We needed an AI solution that would allow us to read mammograms from either the Hologic workstation or from the Intelerad® PACS. ProFound AI, which supports multiple output formats, was able to provide that flexibility. Matt DeweyChief Information Officer, Wake Radiology We decided to adopt ProFound AI because we felt it was the best product available to provide valid CAD markers on DBT. We also found iCAD’s other breast AI solutions enticing, such as PowerLook Density Assessment and ProFound AI Risk, as technologies we would like to assess. Arnold B. HonickMD, Diagnostic Radiology Specialist at RCISee how ProFound Breast Health Suite fits seamlessly into your workflows.Schedule a DemoOur PartnersProFound PartnershipsProud to work with leading industry, research, technology, and advocacy partners. Previous Next Platform Partners Platform Partners Platform Partners Platform Partners Research Partners Channel Partners Channel Partners Platform Partners Platform Partners Integration Partners Platform Partners Integration Partners Platform Partners Platform Partners Integration Partners Integration Partners Integration Partners Integration Partners Integration Partners Integration Partners Integration Partners Integration Partners Integration Partners Platform Partners Platform Partners Platform Partners Platform Partners Platform Partners Integration Partners Research Partners Research Partners Research Partners Research Partners Research Partners See All Partners Previous Next Press ReleaseRadNet’s Wholly-Owned Subsidiary, DeepHealth, Completes Acquisition of iCAD July 17, 2025Los Angeles, CA – July 17, 2025, RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, announced today that it has completed the acquisition of iCAD, Inc. (NASDAQ: ICAD) (“iCAD”), a global leader in AI-powered breast health solutions. The integration… Read More Press ReleaseiCAD Announces Proxy Advisory Firms ISS and Glass Lewis Recommend Stockholders Vote “FOR” Proposed Acquisition by RadNet, Inc. July 8, 2025Nashua, NH – July 8, 2025 – iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”), a global leader in clinically proven AI-powered cancer detection solutions, today announced that leading independent proxy advisory firms Institutional Shareholder Services Inc. (“ISS”) and Glass, Lewis & Co. (“Glass Lewis”) have each recommended that stockholders… Read More Media CoverageThe Role of AI in Empowering Patients and Improving Breast… June 24, 2025eHealth Radio Network Read More BlogUniting for Health Equity on Juneteenth: Why Closing the Breast Cancer Gap Must Be a Global Priority June 17, 2025By Dana Brown, President & CEO, iCAD, Inc. On Juneteenth, we reflect on freedom and the responsibility that comes with it. As we commemorate the emancipation of enslaved people in the United States, we must also recognize the systemic inequities that persist, particularly in healthcare. Breast cancer is the most… Read More Media CoverageUniting for Health Equity on Juneteenth: Why Closing the Breast Cancer Gap Must Be a Global Priority June 17, 2025News Wise Read More BlogReflections from SIIM 2025: Why Interoperability Matters More Than Ever June 3, 2025By Mark Koeniguer, Chief Commercial Officer, iCAD Attending the Society for Imaging Informatics in Medicine (SIIM) annual meeting in Portland was a welcome opportunity to connect with peers and take stock of the growing momentum across imaging IT. The energy from the exhibit floor and sessions, especially around AI and… Read More EventEUSOBI Annual Scientific Meeting 2025 P&J LiveBooth M3Aberdeen, UKSeptember 25-27, 2025 Sep 25 – Sep 27, 2025Join us from September 25-27, 2025 in Aberdeen, UK for the EUSOBI Annual Scientific Meeting 2025, European Society of Breast Imaging! Let’s talk about how we can help optimize your mammography workflows. Have you been following recent improvements in #AI-powered early breast cancer detection? Read More Event29th Annual Mammography in Santa Fe La Fonda HotelSanta Fe, New MexicoAugust 4-8, 2025 Aug 4 – Aug 8, 2025Join us from August 4-8, 2025 in Santa Fe, NM for the 29th Annual Mammography in Santa Fe! Let’s talk about how we can help optimize your mammography workflows. Have you been following recent improvements in #AI-powered early breast cancer detection? Read More WebinarCase Review with ProFound AI Detection Solutions, Presented by Dr. Rafaele Vautrin, Radiologist at Imapole Lyon Villeurbanne Dec 17, 2024Dr. Vautrin, a user of iCAD’s ProFound AI solution for 2D and 3D mammography for nearly two years, shares her experience through a series of clinical cases where the AI-provided insights were crucial in detecting cancer in her patients. Read More WebinarSymposium JFR 2024 Oct 23, 2024Apport des solutions d’intelligence artificielle d’iCAD pour un meilleur dépistage du cancer du sein détection, densité et risque : revue des dernières études cliniques et revue de cas. Présenté par Pr Bruno Boyer, CIMI, Paris Read More Contact UsTogether, we can create a world where cancer can’t hide.Ready to experience how ProFound can save lives?Let’s Connect References1. Mikael Eriksson et al. A risk model for digital breast tomosynthesis to predict breast cancer and guide clinical care. Sci. Transl. Med. 14, eabn3971 (2022). DOI: 10.1126/scitranslmed.abn3971. 2. Eriksson M, Czene K, Strand F, Zackrisson S, Lindholm P, Lång K, Förnvik D, Sartor H, Mavaddat N, Easton D, Hall P. Identification of Women at High Risk of Breast Cancer Who Need Supplemental Screening. Radiology. 2020 Nov;297(2):327-333. doi: 10.1148/radiol.2020201620. Epub 2020 Sep 8. PMID: 32897160. 4. Conant EF, Toledano AY, Periaswamy S, Fotin SV, Go J, Boatsman JE, Hoffmeister JW. Improving Accuracy and Efficiency with Concurrent Use of Artificial Intelligence for Digital Breast Tomosynthesis. Radiol Artif Intell. 2019 Jul 31;1(4):e180096. doi: 10.1148/ryai.2019180096. PMID: 32076660; PMCID: PMC6677281. 5. https://www.nationalbreastcancer.org/early-detection-of-breast-cancer. Accessed 11-01-2023. 6. Lynge E, Vejborg I, Lillholm M, Nielsen M, Napolitano G, von Euler-Chelpin M. Breast density and risk of breast cancer. Int J Cancer. 2023 Mar 15;152(6):1150-1158. doi: 10.1002/ijc.34316. Epub 2022 Oct 27. PMID: 36214783; PMCID: PMC10091988. To give you the best possible experience, this site uses cookies and by continuing to use the site you agree that we can save them on your device. Privacy Policy Continue --- Skip to content About iCADOur Vision: A world where cancer can’t hide. Home› Company OverviewOur MissionTo create a world where cancer can’t hide from innovative artificial intelligence solutions that empower providers and professionals to accurately, reliably and quickly detect cancer and improve outcomes – optimizing every patient’s opportunity to live better, longer lives. FDA Cleared. CE Marked. Health Canada Licensed. Detection. Density. Risk.Our ProFound PortfolioBacked by science, clinical evidence, and proven patient outcomes; our suite of solutions – Detection, Density, and Risk – shine a spotlight on cancer, exposing its hiding place. Empowering you to personalize breast cancer screening like never before.Learn MoreWe’ve earned the trust of thousands of providers and millions of patients.Our extensive, clinically-proven AI solutions have been empowering clinicians and changing patient’s lives for decades.Changing Lives with Measurable ResultsImprove patient care and outcomesSeamless integration into existing workflows & systemsGuidance You Can TrustExtensive, globally-diverse, and rigorously validated data setGlobally certified and regulatory-compliant Radiologists using ProFound report:Finding more cancers earlier, including invasive lobular carcinomasImproved diagnostic accuracy, with less reading time and less stressElevated MQSA scores, indicating higher accuracy in screening detectionReduced misdiagnosis and consistent diagnostic interpretationIncrease in screening volumeReduction in unnecessary recalls and biopsiesExtensive, certified global reach.ProFound solutions are certified and available in over 50 countries.FDA Cleared. CE Marked. Health Canada Licensed.Learn more about us. Our History.Over 20 years of delivering proven deep-learning AI solutions. Our History Powered by Science.Industry leader backed by science, clinical evidence, and proven patient outcomes. Powered by Science Blog | News & EventsGet connected and stay informed. Blog | News & Events iCAD, Inc.2 Townsend West, Suite 6Nashua, NH 03062 USAToll-free: +1 866 280 2239Phone: +1 603 882 5200www.icadmed.comTechnical SupportToll-free: +1 866-280-2239Phone: +1 603-882-5200support@icadmed.com Contact UsTogether, we can create a world where cancer can’t hide.Ready to experience how ProFound can save lives?Let’s Connect To give you the best possible experience, this site uses cookies and by continuing to use the site you agree that we can save them on your device. Privacy Policy Continue --- Skip to content Contact Get in touch with us. DeepHealth 212 Elm St.Somerville, MA 02144 --- Skip to contentBlogHome› Company Overview› Blog June 17, 2025 Uniting for Health Equity on Juneteenth: Why Closing the Breast Cancer Gap Must Be a Global Priority Posted in Awareness & CommunityHealth EquityBy Dana Brown, President & CEO, iCAD, Inc. On Juneteenth, we reflect on freedom and the responsibility that comes with it. As we commemorate the emancipation of enslaved people in the United States, we must also recognize the systemic inequities that persist, particularly in healthcare. Breast cancer is the most... Read More June 3, 2025 Reflections from SIIM 2025: Why Interoperability Matters More Than Ever Posted in Tradeshows & MeetingsProFound AI, SIIMBy Mark Koeniguer, Chief Commercial Officer, iCAD Attending the Society for Imaging Informatics in Medicine (SIIM) annual meeting in Portland was a welcome opportunity to connect with peers and take stock of the growing momentum across imaging IT. The energy from the exhibit floor and sessions, especially around AI and... Read More April 29, 2025 Reflecting on SBI 2025: Advancing Breast Imaging with End-to-End AI-Powered Solutions Posted in Tradeshows & MeetingsProFound AI, SBIAt the iCAD booth, we showcased our latest innovations, partnerships, and celebrated the strides we’re making in AI-powered smarter breast health solutions. Radiologists were excited to see the latest performance of ProFound Detection Version 4.0, our newest FDA-cleared solution designed to enhance breast cancer detection. The response from attendees was... Read More March 12, 2025 iCAD Leadership in Breast Health AI Showcased at ECR 2025 Posted in Tradeshows & MeetingsECR, ProFound AIiCAD is capitalizing on 20+ years of innovation in breast health AI. As the first to bring AI-powered DBT detection to market, iCAD continues to lead the way with wide-ranging AI solutions, cloud-enabled connectivity, and next generation algorithms that are transforming patient care and breast health for the future, including... Read More December 11, 2024 RSNA 2024: Transforming Breast Health through AI Posted in Tradeshows & MeetingsProFound AI, RSNAThe Radiological Society of North America (RSNA) 2024 Annual Meeting once again set the stage for iCAD’s impactful presence, showcasing the latest advancements in breast imaging and artificial intelligence (AI). With over 40,000 attendees—an 18% increase from the previous year—and 715 exhibitors, the event underscored the rapidly growing focus on... Read More October 7, 2024 Overcoming Obstacles to Breast Cancer Screening Posted in Awareness & CommunityOctober BCAMRegular mammograms are a vital tool in the early detection of breast cancer. When caught early, breast cancer is often more treatable, leading to better outcomes and increased survival rates. Yet, many women delay or avoid getting their screening mammograms due to various concerns, fears, and lack of resources. Understanding... Read More September 26, 2024 Ways to Impact Breast Cancer Posted in Awareness & CommunityOctober BCAMOctober is Breast Cancer Awareness Month—a time to come together to raise awareness, support those affected by breast cancer, and advocate for continued research, health equity, and innovation. It’s an important moment for us all to unite, reflect, and take action toward a future where breast cancer no longer poses... Read More August 28, 2024 Revolutionizing AI Breast Cancer Detection: Speed, Scalability, and Security. Posted in Breast Cancer DetectionDeployment, ProFound AIIn an era where technology continuously redefines healthcare, radiologists and breast imaging professionals face the critical task of detecting breast cancer early and more accurately, avoiding the pitfalls of a missed or delayed diagnosis of cancer. Artificial intelligence (AI) is revolutionizing breast cancer detection by providing radiologists with powerful tools... Read More June 27, 2024 Quality Images. Precise Detection. Elevated Patient Care. Posted in AI Workflows & IntegrationsProFound AIPatients are more informed than ever and are actively seeking breast health care providers who use cutting edge technology to help improve mammography quality and breast cancer screening effectiveness. As patient volumes surge and health facilities face a critical shortage of radiologists and technologists, imaging centers often face the growing... Read More June 18, 2024 Uniting for Health Equity: Addressing Breast Cancer Disparities Posted in Awareness & CommunityHealth EquityAs we approach Juneteenth, a day marking the emancipation of enslaved people in the U.S., it’s a time to reflect on the progress we’ve made towards equality and justice. However, it’s also a time to acknowledge the persistent disparities that continue to affect Black communities, particularly in healthcare. One such... Read More 1 2 3 … 6 Next Search CategoriesAI Workflows & Integrations (7)Awareness & Community (17)Breast Cancer Detection (9)Breast Density (8)Research & Case Studies (7)Tradeshows & Meetings (7)Show more To give you the best possible experience, this site uses cookies and by continuing to use the site you agree that we can save them on your device. Privacy Policy Continue